LCI - Lannett Co., Inc.
Previous close
0.6855
0 0%
Share volume: 18,619
Last Updated: Wed 19 Apr 2023 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.00
0.00%
View ratios
| Fiscal Date | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2021-11-04 | 2022-02-04 | 2022-05-10 | 2022-08-25 | 2022-11-03 | 2023-02-02 | |
| Total revenue | 101.525 M | 86.508 M | 78.357 M | 74.189 M | 75.079 M | 80.894 M | |
| Cost of revenue | 81.008 M | 76.990 M | 72.658 M | 63.826 M | 61.285 M | 65.258 M | |
| Gross profit | 20.517 M | 9.518 M | 5.699 M | 10.363 M | 13.794 M | 15.636 M | |
| -53.61% | -40.12% | 81.84% | 33.11% | 13.35% | |||
| Operating expenses | 24.669 M | 23.538 M | 23.379 M | 31.799 M | 23.876 M | 23.245 M | |
| Selling general and admin | 18.905 M | 18.791 M | 17.572 M | 25.755 M | 16.697 M | 18.317 M | |
| Research and development | 5.764 M | 4.747 M | 5.807 M | 6.044 M | 7.179 M | 4.928 M | |
| Total expenses | 109.673 M | 104.336 M | 98.658 M | 98.131 M | 86.356 M | 89.861 M | |
| -4.87% | -5.44% | -0.53% | -12.00% | 4.06% | |||
| Operating income | -8.148 M | -17.828 M | -20.301 M | -23.942 M | -11.277 M | -8.967 M | |
| Ebit | -8.148 M | -17.828 M | -20.301 M | -23.942 M | -11.277 M | -8.967 M | |
| Pretax income | -22.400 M | -82.453 M | -36.263 M | -92.808 M | -27.985 M | -36.276 M | |
| 268.09% | -56.02% | 155.93% | -69.85% | 29.63% | |||
| Income tax | -58.000 K | -1.368 M | -1.365 M | 487.000 K | 34.000 K | 32.000 K | |
| Net income basic | -22.342 M | -81.085 M | -34.898 M | -93.295 M | -28.019 M | -36.308 M | |
| -262.93% | 56.96% | -167.34% | 69.97% | -29.58% | |||
| Net income | -22.342 M | -81.085 M | -34.898 M | -93.295 M | -28.019 M | -36.308 M | |
| -262.93% | 56.96% | -167.34% | 69.97% | -29.58% |